Skip to content

The application of electroacupuncture therapy under the ERAS protocol during the perioperative period of liver transplantation

The application of electroacupuncture therapy under the ERAS protocol during the perioperative period of liver transplantation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103455
Enrollment
Unknown
Registered
2025-05-29
Start date
2024-08-13
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis, liver cancer, etc

Interventions

Electroacupuncture Group:Transcutaneous acupoint electrical stimulation combined with electroacupuncture treatment
Sham Electroacupuncture Group:Only accept ERAS standardized perioperative management and do not perform percutaneous acupoint electrical stimulation combined with electroacupuncture treatment.

Sponsors

West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 and above who undergo liver transplantation for the first time; 2. Patients with tracheal intubation removed in the operating room after liver transplantation surgery.

Exclusion criteria

Exclusion criteria: 1. Suffer from mental disorders; 2. Have a history of drug abuse or alcoholism; 3. Received acupuncture treatment within one month before enrollment; 4. There is a pacemaker or other electrical stimulation device.

Design outcomes

Primary

MeasureTime frame
Exhaust time;

Secondary

MeasureTime frame
Defecation time;Infectious complications;clavier-D;Hospital stay;

Countries

China

Contacts

Public ContactYang Jiaying

West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, China

doctoryjy@scu.edu.cn+86 189 8060 2047

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026